WASHINGTON (MedPage Today) — Patients in U.S. addiction treatment programs will no longer have to wait a year to be eligible for therapy with buprenorphine (Suboxone), according to a new federal rule. (Source: MedPage Today Psychiatry)
Feds Ease Access to Suboxone
Previous post: Buprenorphine May Not Be as Safe as You Think: A Pediatric Fatality From Unintentional Exposure
Next post: A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine
